Papers/PMID:23028897
A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin.
PloS one2012The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
selenium atom — no detected effect on serum adiponectin
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The null effect of Se supplementation on adiponectin levels did not differ significantly by sex (P for treatment-by-sex interaction = 0.39; Table S2).”
Quoted verbatim from A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin.. - Study
- RCT
- Dose
- 100, 200 or 300 µg Se/d as high-selenium yeast (SelenoPrecise) versus placebo yeast, minimum six months
- Population
- Elderly volunteers aged 60-74 years of relatively low selenium status, UK; three active dose groups compared with placebo, six months
A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin.2012PMID:23028897Permalink